Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV
Aladdin Mohammad, Professor of Rheumatology at Lund University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers, adding:
”I am pleased to share our latest publication: Hypogammaglobulinaemia in patients with ANCA-associated vasculitis treated with rituximab
Rituximab has become a cornerstone in the management of ANCA-associated vasculitis (AAV), but concerns remain regarding treatment-related hypogammaglobulinaemia and the associated risk of infections.
In this population-based Swedish cohort of patients with AAV treated with rituximab, we found that:
- Hypogammaglobulinaemia developed in 45% of patients.
- Most cases were mild to moderate.
- Lower baseline IgG levels independently predicted the development of hypogammaglobulinaemia.
- Hypogammaglobulinaemia was not associated with an increased risk of severe infections in this cohort.
These findings emphasize the importance of measuring IgG levels before initiating rituximab and monitoring them throughout treatment, particularly in patients with lower baseline IgG concentrations.
Many thanks to my co-authors Jens Rathmann, Hiba Kadhem, Mårten Segelmark, and David Jayne for their excellent collaboration.”
Title: Hypogammaglobulinaemia in patients with ANCA-associated vasculitis treated with rituximab
Authors: Jens Rathmann, Hiba Kadhem, Mårten Segelmark, David Jayne, Aladdin J. Mohammad

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI
-
Nov 17, 2026, 13:30Stacy E. Croteau: Oral and Dental Care in Pediatric Patients With Bleeding Disorders
-
Nov 17, 2026, 13:19Efe Saglam: Cannabis Use and Cardiac Conduction
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?